Close Menu

LifeCodexx, a subsidiary of German sequencing service provider GATC Biotech, plans to launch its non-invasive prenatal trisomy 21 test, called LifeCodexx PraenaTest, in the second quarter of this year, the company said this week.

The firm has obtained more than 500 blood samples for its ongoing prospective blinded clinical study, which is comparing the test with conventional invasive testing methods.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A genetic genealogy analysis helped secure the release of a California man from prison after getting his murder conviction overturned, the Guardian reports.

Researchers have uncovered large bacteriophages whose genomes include translational machinery, Live Science reports.

Technology Review discusses the concerns that come along with the ability to quickly synthesize viruses like SARS-CoV-2.

In PNAS this week: role for Myc in alternative splicing regulation in prostate cancer, variation in methylation in Arabidopsis, and more.